|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
��Ӧ��Ƥ�� |
|
���� |
| ��������������� | |
|
���������� |
|
���ַ���У |
| PubMed | |
|
Article by ���������� |
|
Article by ���ַ���У |
��������Ӧ��Ƥ��
����������1, ���ַ���У2
1. ɽ��ʡ����ҽԺƤ����;
2. ������ѧ����ҽԺƤ����
��Ӧ��Ƥ�ײ�����,����������δ��ȫ����,�о���ʾijЩ����ĸ�Ⱦ���������Ӧ��Ƥ�ķ���������йء����ľ���Ӧ��Ƥ���߶�ijЩ�����Я����������ܵ�����ѧ������²�������ص����ƽ�����������
1. ɽ��ʡ����ҽԺƤ����;
2. ������ѧ����ҽԺƤ����
1. ɽ��ʡ����ҽԺƤ����;
2. ������ѧ����ҽԺƤ����
[2] Namura S, Nishijima S, Higashida T, et al. Staphylococcus aureus isolated from nostril anteriors and subungual spaces of the hand:comparative study of medical staff, patients, and normal controls. J Dermatol, 1995,22(3):175-180.
[3] Higaki S, Morohashi M, Yamagishi T, et al. Comparative study of staphylococci from the skin of atopic dermatitis patients and from healthy subjects. Int J Dermatol, 1999,38(4):265-269.
[4] Broberg A, Faergemann J. Topical antimycotic treatment of atopic dermatitis in the head/neck area. A double-blind randomised study. Acta Derm Venereol, 1995,75(1):46-49.
[5] Hiruma M, Maeng DJ, Kobayashi M, et al. Fungi and atopic dermatitis. Nippon Ishinkin Gakkai Zasshi, 1999,40(2):79-83.
[6] Arzumanian VG, Mokronosova MA, Samuilova TL, et al. Yeast-like ftngi on the skin of patients with atopic dermatitis. Zh Mikrobiol Epidemiol Immunobiol, 1998,(3):10-13.
[7] Goodyear HM, Davies JA, McLeish P, et al. Growth of herpes simplex virus ty pe I on skin explants of atopic eczema. Clin Exp Dermatol, 1996,21(3):185-189.
[8] Brook I, Frazier EH, Yeager JK. Microbiology of infected atopic dermatitis. Int J Dermatol, 1996,35(11):791-793.
[9] McFadden JP, Noble WC, Camp RD. Superantigenic exotoxin-secreting potential of staphylococci isolated from atopic eczematous skin. Br J Dermatol, 1993,128(6):631-632.
[10] Morishita Y, Tada J, Sato A, et al. Possible influences of Staphylococcu.s aureus on atopic dermatitis-the colonizing features and the effects of staphylococcal enterotoxins. Clin Exp Allergy, 1999,29(8):1110-1117.
[11] Matsui K, Motohashi R, Nishikawa A. Cell wall components of Staphylococcus aureus induce interleukin-5 production in patients with atopic dermatitis. J Interferon Cytokine Res, 2000,20(3):321-324.
[12] Nissen D, Pedersen LJ, Skov PS, et al. IgE-binding components of staphylococcal enterotoxins in patients with atopic dermatitis. Ann Allergy Asthma Immtnol, 1997,79(5):403-408.
[13] Bunikowski R, Mielke M, Skarabis H, et al. Prevalence and role of serum IgE antibodies to the Staphylococcus aureus-derived superantigens SEA and SEB in children with atopic dermatitis. J Allergy Clin Immunol, 1999,103(1 Pt 1):119-124.
[14] Tengvall-Linder M, Johansson C, Scheynius A, et al. Positive atopy patch test reactions to Pityosporum orbiculare in atopic dermatits patients. Clin Exp Allergy, 2000,30(1):122-131.
[15] Tengvall-Linder M, Johansson C, Bengtsson A, et al. Pitrosporum orbiculare-reactive T-cell lines in atopic dermatitis patients and healthy individuals. Scand J Immunol, 1998,47(2):152-158.
[16] Faergemamn J. Pityrosporum yeasts-what's new? Mycoses, 1997,40(Suppl 1):29-32.
[17] Wessels MW, Doekes G, van Ieperen-van Kijk AG, et al. IgE antibodies to Pitrosporum ovale in atopic dermatitis. Br J Dermatol, 1991,125(3):227-232.
[18] Lintu P, Savolainen J, Kalimo K. IgE antibodies to protein and nannan antigens of Pitrosporum ovale in atopic dermatitis patients. Clin Exp Allergy, 1997,27(1):87-95.
[19] Savolainen J, Kosonen J, Lintu P, et al. Canadida albicans mannan-and protein-induced humoral, cellular and cytokine responses in atopic dermatitis patients. Clin Exp Allergy, 1999,29(6):824-831.
[20] Tanaka M, Aiba S, Takahashi K, et al. Reduced proliferative responses of peripheral blood mononuclear cells specifically to Candida albicans antigen in patients with atopic dermatitis-comparison with their normal reactivity to bacterial superantigens. Arch Dermatol Res, 1996,288(9):495-499.
[21] Scalabrin DM, Bavbek S, Perzanowski MS, et al. Use of specific IgE in assessing the relevance of fungal and dust mite allergens to atopic dermatitis:a comparison with asthmatic and nonasthmatic control subjects. J Allergy Clin Immunol, 1999,104(6):1273-1279.
[22] Baran-Raunstrup K, Miedzobrodzki J, Temowitz T. Characteristics of Staphylococcus aureus isolates from atopic dermatitis with reference to proteolytic activity. Acta Microbiol Pol, 1998,47(2):167-175.
[23] Back O, Scheynius A, Johansson SG. Ketoconazole in atopic dermatitis:therapeutic response is correlated with decrease in serum IgE. Arch Dermatol Res, 1995,287(5):448-451.
[24] Adachi A, Horikawa T, Ichihashi M, et al. Role of candida allergen in atopic dermatitis and efficacy of oral therapy with various antifungal agents. Arerugi, 1999,48(7):719-725.